Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice

BACKGROUND: The global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the need to develop safe and effective vaccines with a top priority. Multiple vaccine candidates are under development, and several vaccines are cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tong, Ren, Yi, Li, Shuangqin, Lu, Xin, Lei, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097247/
https://www.ncbi.nlm.nih.gov/pubmed/33952256
http://dx.doi.org/10.1186/s12934-021-01584-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097247/
https://www.ncbi.nlm.nih.gov/pubmed/33952256
http://dx.doi.org/10.1186/s12934-021-01584-5

Ejemplares similares